Main content start
Executive Director, Sarafan ChEM-H and Innovative Medicines Accelerator (IMA)
Dr. Elizabeth Ponder joined Sarafan ChEM-H in 2014 and is currently the Executive Director of Sarafan ChEM-H and Stanford's Innovative Medicines Accelerator (IMA). Dr. Ponder completed her Ph.D. and postdoctoral training at Stanford University in the laboratory of Dr. Matthew Bogyo. Her past work has included promoting public-private partnerships in the non-profit sector, managing multidisciplinary research in the higher education sector, and business development consulting in the for-profit biotech sector. Dr. Ponder joined ChEM-H from the University of California, Berkeley where she served as the Executive Director of the Henry Wheeler Center for Emerging & Neglected Diseases (CEND).